Idiopathic hypersomnia: does first to approval mean first-line treatment?
Lancet Neurol
.
2022 Jan;21(1):25-26.
doi: 10.1016/S1474-4422(21)00419-1.
Author
Lynn Marie Trotti
1
Affiliation
1
Department of Neurology and Sleep Center, Emory University School of Medicine, Atlanta, GA30329, USA. Electronic address: Lbecke2@emory.edu.
PMID:
34942131
PMCID:
PMC9089235
DOI:
10.1016/S1474-4422(21)00419-1
No abstract available
Publication types
Comment
MeSH terms
Disorders of Excessive Somnolence*
Humans
Idiopathic Hypersomnia*
Narcolepsy*
Grants and funding
R01 NS111280/NS/NINDS NIH HHS/United States